US$ 23.63
dual agonist glp 1 glucagon GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes TrimRX | GLP-1 vs GIP:
Description
In another systematic review, Clapp et al

GLP-1 and glucagon co-agonists Glucagon is secreted from the pancreatic a-cells and the main physiological site of action is the liver to increase hepatic glucose production [60]
Although GLP-1RAs can play a favorable role in improving heart failure based on pre-clinical studies, whereas some clinical evidence relevantly have reported that GLP-1RAs treatment could be associated with adverse heart failure events, eg
Lancet Diabetes Endocrinol 7(10):776785 Muskiet MHA, Smits MM, Morsink LM, Diamant M (2014) The gutrenal axis: do incretin-based agents confer renoprotection in diabetes

H.LahiriD

Most patients notice improved blood sugar control and changes in appetite within a few weeks
